Malaysian Genomics Resource (0155) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.053x

Based on the latest financial reports, Malaysian Genomics Resource (0155) has a cash flow conversion efficiency ratio of 0.053x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM1.01 Million ≈ $253.08K USD) by net assets (RM18.88 Million ≈ $4.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Malaysian Genomics Resource for the company's overall valuation and market capitalisation.

Malaysian Genomics Resource - Cash Flow Conversion Efficiency Trend (2015–2026)

This chart illustrates how Malaysian Genomics Resource's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Malaysian Genomics Resource Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Malaysian Genomics Resource ranked by their cash flow conversion efficiency. Explore Malaysian Genomics Resource cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Frigo-Pak Gida Maddeleri Sanayi ve Ticaret AS IS:FRIGO	0.179x
PIMS Inc. KQ:347770	0.011x
Acrinova AB ST:ACRI-A	0.092x
Rcm Beteiligungs AG F:RCMN	N/A
Airthings ASA OL:AIRX	-0.177x
Magnum Ventures Limited NSE:MAGNUM	0.008x
Pintec Technology Holdings Ltd NASDAQ:PT	4.634x
ADTIGER CORP.LTD.DL-0005 F:55U	N/A

Annual Cash Flow Conversion Efficiency for Malaysian Genomics Resource (2015–2026)

The table below shows the annual cash flow conversion efficiency of Malaysian Genomics Resource from 2015 to 2026. View Malaysian Genomics Resource (0155) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-06-30	RM14.78 Million ≈ $3.71 Million	RM1.10 Million ≈ $277.42K	0.075x	+282.15%
2025-06-30	RM18.16 Million ≈ $4.56 Million	RM-744.97K ≈ $-187.04K	-0.041x	+96.33%
2024-06-30	RM22.35 Million ≈ $5.61 Million	RM-24.97 Million ≈ $-6.27 Million	-1.117x	-35.64%
2023-06-30	RM26.79 Million ≈ $6.73 Million	RM-22.07 Million ≈ $-5.54 Million	-0.824x	-53707.58%
2022-06-30	RM37.05 Million ≈ $9.30 Million	RM56.92K ≈ $14.29K	0.002x	+101.05%
2021-06-30	RM17.93 Million ≈ $4.50 Million	RM-2.64 Million ≈ $-661.90K	-0.147x	-112.93%
2020-06-30	RM10.26 Million ≈ $2.58 Million	RM11.67 Million ≈ $2.93 Million	1.137x	+2735.15%
2019-06-30	RM15.93 Million ≈ $4.00 Million	RM-687.64K ≈ $-172.64K	-0.043x	+86.54%
2018-06-30	RM19.77 Million ≈ $4.96 Million	RM-6.34 Million ≈ $-1.59 Million	-0.321x	-312.09%
2017-06-30	RM24.30 Million ≈ $6.10 Million	RM3.67 Million ≈ $922.57K	0.151x	-20.39%
2016-06-30	RM19.39 Million ≈ $4.87 Million	RM3.68 Million ≈ $924.53K	0.190x	+746.88%
2015-06-30	RM17.65 Million ≈ $4.43 Million	RM395.83K ≈ $99.38K	0.022x	--

About Malaysian Genomics Resource

KLSE:0155 Malaysia Diagnostics & Research

Market Cap

$13.83 Million

RM55.09 Million MYR

Market Cap Rank

#26306 Global

#778 in Malaysia

Share Price

RM0.37

Change (1 day)

+0.00%

52-Week Range

RM0.17 - RM0.38

All Time High

RM2.72